DK0729352T3 - Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter - Google Patents

Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter

Info

Publication number: DK0729352T3
Authority: DK; Denmark
Prior art keywords: arachidonic acid; acid metabolites; liposomes containing; interdigitation; containing arachidonic
Prior art date: 1993-11-16

Application number

DK95901236T

Other languages

English (en)

Inventor

Andrew S Janoff

Sharma R Minchey

Original Assignee

Liposome Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-16

Filing date

1994-11-15

Publication date

1999-09-20

1994-11-15 Application filed by Liposome Co Inc filed Critical Liposome Co Inc

1999-09-20 Application granted granted Critical

1999-09-20 Publication of DK0729352T3 publication Critical patent/DK0729352T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Hematology (AREA)
Neurology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Dispersion Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Manufacturing Of Micro-Capsules (AREA)

DK95901236T 1993-11-16 1994-11-15 Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter DK0729352T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15317693A	1993-11-16	1993-11-16
PCT/US1994/013063 WO1995013797A1 (en)	1993-11-16	1994-11-15	Interdigitation-fusion liposomes containing arachidonic acid metabolites

Publications (1)

Publication Number	Publication Date
DK0729352T3 true DK0729352T3 (da)	1999-09-20

Family

ID=22546097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95901236T DK0729352T3 (da)	1993-11-16	1994-11-15	Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter

Country Status (13)

Country	Link
EP (1)	EP0729352B1 (da)
JP (1)	JP3798016B2 (da)
KR (1)	KR960705546A (da)
AT (1)	ATE176397T1 (da)
AU (1)	AU681469B2 (da)
CA (1)	CA2175350A1 (da)
DE (1)	DE69416425T2 (da)
DK (1)	DK0729352T3 (da)
ES (1)	ES2126868T3 (da)
FI (1)	FI962080A7 (da)
GR (1)	GR3030123T3 (da)
NO (1)	NO312808B1 (da)
WO (1)	WO1995013797A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU682753B2 (en) *	1994-01-11	1997-10-16	Liposome Company, Inc., The	Treatment using arachidonic acid metabolite and particulate formulations
JP2003342196A (ja) *	2002-05-31	2003-12-03	Mukku:Kk	静脈注射用組成物、その製造法およびその製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5262168A (en) *	1987-05-22	1993-11-16	The Liposome Company, Inc.	Prostaglandin-lipid formulations
WO1988009170A1 (en) *	1987-05-22	1988-12-01	The Liposome Company, Inc.	Prostaglandin-lipid formulations
AU652552B2 (en) *	1990-01-12	1994-09-01	Liposome Company, Inc., The	Interdigitation-fusion liposomes and gels
ATE176401T1 (de) *	1991-05-07	1999-02-15	Liposome Co Inc	Liposomale prostaglandinformulierungen
JPH05139977A (ja) *	1991-05-17	1993-06-08	Green Cross Corp:The	プロスタグランジン類リポソーム複合体を充填した注射器

1994
- 1994-11-15 KR KR1019960702392A patent/KR960705546A/ko not_active Abandoned
- 1994-11-15 ES ES95901236T patent/ES2126868T3/es not_active Expired - Lifetime
- 1994-11-15 DE DE69416425T patent/DE69416425T2/de not_active Expired - Fee Related
- 1994-11-15 JP JP51453295A patent/JP3798016B2/ja not_active Expired - Fee Related
- 1994-11-15 AU AU10555/95A patent/AU681469B2/en not_active Ceased
- 1994-11-15 DK DK95901236T patent/DK0729352T3/da active
- 1994-11-15 CA CA002175350A patent/CA2175350A1/en not_active Abandoned
- 1994-11-15 AT AT95901236T patent/ATE176397T1/de not_active IP Right Cessation
- 1994-11-15 EP EP95901236A patent/EP0729352B1/en not_active Expired - Lifetime
- 1994-11-15 WO PCT/US1994/013063 patent/WO1995013797A1/en not_active Ceased
- 1994-11-15 FI FI962080A patent/FI962080A7/fi not_active IP Right Cessation
1996
- 1996-05-13 NO NO19961949A patent/NO312808B1/no not_active IP Right Cessation
1999
- 1999-04-30 GR GR990401205T patent/GR3030123T3/el unknown

Also Published As

Publication number	Publication date
FI962080A0 (fi)	1996-05-15
FI962080L (fi)	1996-05-15
CA2175350A1 (en)	1995-05-26
EP0729352A1 (en)	1996-09-04
WO1995013797A1 (en)	1995-05-26
DE69416425D1 (de)	1999-03-18
NO961949L (no)	1996-05-13
ES2126868T3 (es)	1999-04-01
EP0729352B1 (en)	1999-02-03
GR3030123T3 (en)	1999-07-30
NO312808B1 (no)	2002-07-08
KR960705546A (ko)	1996-11-08
ATE176397T1 (de)	1999-02-15
FI962080A7 (fi)	1996-05-15
AU1055595A (en)	1995-06-06
AU681469B2 (en)	1997-08-28
NO961949D0 (no)	1996-05-13
DE69416425T2 (de)	1999-06-10
JPH09505302A (ja)	1997-05-27
JP3798016B2 (ja)	2006-07-19

Publication	Publication Date	Title
DK0726764T3 (da)	1999-12-20	Multilamel-liposomale arachidonsyremetabolitformuleringer
ES2145318T3 (es)	2000-07-01	Imidazo(4,5-c)quinolin-aminas.
ES2001035A6 (es)	1988-04-16	Herrete para la oreja de una animal
FI973320L (fi)	1997-10-13	Kiinteitä aktiiviainetta sisältäviä valmisteita
ES2148593T3 (es)	2000-10-16	Compuestos retinoides trienoicos novedosos y metodos.
EP1048659A4 (en)	2002-11-20	RETINOID RECEPTOR AGONISTS
DE69633293D1 (de)	2004-10-07	Für das Auge unschädliche Übertragung gefährlicher Laserstrahlen
ES2174293T3 (es)	2002-11-01	Microesferas farmaceuticas de acido valproico para la administracion oral.
AR001035A1 (es)	1997-08-27	Metodo para encarretar una tira de alambres, colocados juntos entre si, como alambres encolados.
DK0729352T3 (da)	1999-09-20	Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter
ES2192669T3 (es)	2003-10-16	Uso de proteinas como agentes frente a enfermedades autoinmunes.
ES2141978T3 (es)	2000-04-01	Retinoides triciclicos, metodos para su produccion y uso.
IT8222566A0 (it)	1982-07-26	Derivato dell'acido ursolico farmacologicamente attivo.
DE69722178D1 (de)	2003-06-26	Therapeutischer wirkstoff für augenerkrankungen
FI965001A7 (fi)	1997-06-16	Kantoankkuri lisäkuoren kiinnittämiseksi kantavaan kuoreen
IT8323951A0 (it)	1983-11-30	Procedimento per la sintesi di acido ursodesossicolico coniugato con la taurina.
IT1265422B1 (it)	1996-11-22	Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione
ES2105973B1 (es)	1998-05-01	Composicion liposomal para la regeneracion celular de la piel.
UA22016A (uk)	1998-04-30	Препарат для саhації сперми бугаїв "декомсаh"
SE8207186D0 (sv)	1982-12-16	Terapeutiskt aktiva, membranstabiliserande medel
ITBO950563A0 (it)	1995-11-30	Sistema per la sostituzione di accumulatori elettrici.
KR970025728U (ko)	1997-06-20	편향 요크 고정 구조
ES1018239Y (es)	1992-07-01	Ensamblador para la fabricacion de marcos.